Clinical Trial Update: A Study of Setmelanotide in Patients With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial of setmelanotide for Prader-Willi syndrome, with obesity and hyperphagia as related conditions. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prader-willi Syndrome

Drugs mentioned

• IMCIVREE (setmelanotide)

Snippet

Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Prader-Willi Syndrome, Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING